104 related articles for article (PubMed ID: 1690551)
1. A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group.
Roberts RB; Hollinger FB; Parks WP; Rasheed S; Laurence J; Heseltine PN; Makuch RW; Lubina JA; Johnson KM
AIDS; 1990 Jan; 4(1):67-72. PubMed ID: 1690551
[TBL] [Abstract][Full Text] [Related]
2. A phase 1 study of ribavirin in human immunodeficiency virus-infected patients.
Roberts RB; Jurica K; Meyer WA; Paxton H; Makuch RW
J Infect Dis; 1990 Sep; 162(3):638-42. PubMed ID: 2117625
[TBL] [Abstract][Full Text] [Related]
3. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.
Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD
J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173
[TBL] [Abstract][Full Text] [Related]
4. A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group.
Roberts RB; Dickinson GM; Heseltine PN; Leedom JM; Mansell PW; Rodriguez S; Johnson KM; Lubina JA; Makuch RW
J Acquir Immune Defic Syndr (1988); 1990; 3(9):884-92. PubMed ID: 1974628
[TBL] [Abstract][Full Text] [Related]
5. Multicenter clinical trial of oral ribavirin in symptomatic HIV-infected patients. The Ribavirin ARC Study Group.
J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):32-41. PubMed ID: 8417172
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
Lane HC; Davey V; Kovacs JA; Feinberg J; Metcalf JA; Herpin B; Walker R; Deyton L; Davey RT; Falloon J
Ann Intern Med; 1990 Jun; 112(11):805-11. PubMed ID: 1971503
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
Crumpacker C; Heagy W; Bubley G; Monroe JE; Finberg R; Hussey S; Schnipper L; Lucey D; Lee TH; McLane MF
Ann Intern Med; 1987 Nov; 107(5):664-74. PubMed ID: 3662279
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
[TBL] [Abstract][Full Text] [Related]
9. Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.
Burgard M; Sansonetti P; Vittecoq D; Descamps P; Guetard D; Herson S; Rozenbaum W; Rouzioux C
AIDS; 1989 Oct; 3(10):665-8. PubMed ID: 2480798
[TBL] [Abstract][Full Text] [Related]
10. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
11. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
12. Racial heterogeneity of HIV antigenemia in people with HIV infection.
Chaisson RE; Fuchs E; Stanton DL; Quinn TC; Hendricksen C; Bartlett JG; Farzadegan H
AIDS; 1991 Feb; 5(2):177-80. PubMed ID: 1903261
[TBL] [Abstract][Full Text] [Related]
13. Clinical, virologic, and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men.
Schulof RS; Parenti DM; Simon GL; Paxton H; Meyer WA; Schlesselman SB; Courtless J; LeLacheur S; Sztein MB
J Acquir Immune Defic Syndr (1988); 1990; 3(5):485-92. PubMed ID: 1691287
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV-1 p24 antigenemia in African and North American populations and correlation with clinical status.
Brown C; Kline R; Atibu L; Francis H; Ryder R; Quinn TC
AIDS; 1991 Jan; 5(1):89-92. PubMed ID: 1905553
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of human immunodeficiency virus in vertically infected infants and children.
Alimenti A; Luzuriaga K; Stechenberg B; Sullivan JL
J Pediatr; 1991 Aug; 119(2):225-9. PubMed ID: 1677684
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
[TBL] [Abstract][Full Text] [Related]
17. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.
Nishanian P; Huskins KR; Stehn S; Detels R; Fahey JL
J Infect Dis; 1990 Jul; 162(1):21-8. PubMed ID: 2113075
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
[TBL] [Abstract][Full Text] [Related]
19. Transient elevation of serum HIV antigen levels associated with intercurrent infection.
Claydon EJ; Bennett J; Gor D; Forster SM
AIDS; 1991 Jan; 5(1):113-4. PubMed ID: 1905552
[No Abstract] [Full Text] [Related]
20. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
